We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-4.68%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.7B
AUM Growth
-$815M
(-4.4%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
0.95%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
3,210
New
168
Increased
1,509
Reduced
1,241
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$41.2M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$30.6M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$29.6M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$28.3M |
| 5 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$26.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$46M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$45.2M |
| 3 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$41.1M |
| 4 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$28.8M |
| 5 |
SPDR Gold Trust
GLD
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.86% |
| 2 | Financials | 4.76% |
| 3 | Consumer Discretionary | 4.5% |
| 4 | Healthcare | 4.18% |
| 5 | Consumer Staples | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PACW
2551
DELISTED
PacWest Bancorp
PACW
| $243K | ﹤0.01% |
10,736
-8,294
| -44% | -$223K |
|
2552
John Marshall Bancorp
JMSB
$330M
| $242K | ﹤0.01% |
9,842
| – | – |
|
2553
Murphy Oil
MUR
$4.97B
| $242K | ﹤0.01% |
6,890
-10,209
| -60% | -$353K |
|
2554
Sabesp
SBS
$16.2B
| $242K | ﹤0.01% |
137,091
| – | – |
|
2555
Deckers Outdoor
DECK
$12.6B
| $241K | ﹤0.01% |
+4,626
| New | +$241K |
|
2556
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$311M
| $241K | ﹤0.01% |
12,691
+1,130
| +10% | +$25.2K |
|
2557
Bank First Corp
BFC
$1.76B
| $240K | ﹤0.01% |
3,132
-1,272
| -29% | -$99.2K |
|
2558
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $239K | ﹤0.01% |
14,792
-2,983
| -17% | -$53.1K |
|
2559
Hartford Multifactor Emerging Markets ETF
ROAM
$111M
| $239K | ﹤0.01% |
13,266
-207
| -2% | -$4.09K |
|
2560
Stellantis
STLA
$20B
| $239K | ﹤0.01% |
19,985
+413
| +2% | +$5.55K |
|
2561
First Citizens BancShares
FCNCA
$25.7B
| $238K | ﹤0.01% |
+299
| New | +$234K |
|
2562
Home BancShares
HOMB
$6.26B
| $238K | ﹤0.01% |
10,592
-12,331
| -54% | -$286K |
|
|
IGA
2563
Voya Global Advantage and Premium Opportunity Fund
IGA
$157M
| $238K | ﹤0.01% |
28,243
+1,819
| +7% | +$16.5K |
|
2564
International Seaways
INSW
$4.69B
| $238K | ﹤0.01% |
+6,767
| New | +$187K |
|
2565
RingCentral
RNG
$5.32B
| $238K | ﹤0.01% |
5,962
+842
| +16% | +$40.4K |
|
2566
Zillow
Z
$7.71B
| $238K | ﹤0.01% |
8,303
-2,080
| -20% | -$72.2K |
|
2567
C.H. Robinson
CHRW
$17.5B
| $237K | ﹤0.01% |
2,463
+182
| +8% | +$19.6K |
|
|
GCV
2568
Gabelli Convertible and Income Securities Fund
GCV
$95.5M
| $237K | ﹤0.01% |
47,644
+2,151
| +5% | +$11.6K |
|
2569
UiPath
PATH
$7.79B
| $237K | ﹤0.01% |
18,818
+1,621
| +9% | +$28.4K |
|
2570
Safety Insurance
SAFT
$1.52B
| $237K | ﹤0.01% |
2,904
+212
| +8% | +$19.1K |
|
2571
Goldman Sachs BDC
GSBD
$1.11B
| $236K | ﹤0.01% |
+16,323
| New | +$276K |
|
|
ABMD
2572
DELISTED
Abiomed Inc
ABMD
| $236K | ﹤0.01% |
960
-18
| -2% | -$4.86K |
|
|
DOO
2573
Bombardier Recreational Products
DOO
$4.76B
| $235K | ﹤0.01% |
3,814
+353
| +10% | +$24.9K |
|
|
DX
2574
Dynex Capital
DX
$3.24B
| $235K | ﹤0.01% |
20,179
+822
| +4% | +$12.8K |
|
2575
iShare MSCI Eurozone ETF
EZU
$9.94B
| $235K | ﹤0.01% |
7,333
+1,211
| +20% | +$43.5K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Cambridge Investment Research Advisors held 3,210 positions worth $17.7B, down 4.4% from $18.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q3 2022 filing shows 168 new, 1,509 increased, 1,241 reduced and 160 closed positions. Its largest new stake was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M. The largest sale was iShares S&P Small-Cap 600 Value ETF, an estimated $46M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q3 2022 buy was JPMorgan BetaBuilders US Equity ETF: 201,011 shares worth $12.9M.
- Cambridge Investment Research Advisors added most to First Trust Enhanced Short Maturity ETF in Q3 2022, an estimated $41.2M increase.
- Cambridge Investment Research Advisors's biggest Q3 2022 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $46M.
- Cambridge Investment Research Advisors fully exited Invesco DB Energy Fund in Q3 2022, selling an estimated $5.88M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $17.7B portfolio in Q3 2022.
- Cambridge Investment Research Advisors opened 168 new positions and closed 160 in Q3 2022.
- Cambridge Investment Research Advisors's portfolio value fell 4.4% quarter-over-quarter to $17.7B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.